-
Recent UK economic data shows sluggish growth, with a 0.1% rise in August and downward revisions for July. Public finances are under pressure, with a widening deficit and high borrowing, complicating the upcoming budget. Political and global uncertainties add to the economic outlook's fragility.
-
Leading companies including Microsoft, JPMorgan, Walmart, and Goldman Sachs are rapidly expanding their AI initiatives. They focus on in-house model development, workforce training, and integrating AI into operations, amid ongoing debates about job impacts and strategic advantages. The story highlights recent investments, partnerships, and workforce transformations as of November 2025.
-
On December 1-2, 2025, WHO issued its first guidelines recommending long-term use of GLP-1 drugs like Wegovy and Mounjaro for obesity treatment, recognizing obesity as a chronic disease. The US government finalized deals lowering prices for these drugs under Medicare and Medicaid, expanding coverage to more patients. Despite benefits, studies show weight and health gains reverse if treatment stops, highlighting need for ongoing care.
-
Economists warn of five key risks for 2026, including US growth, global manufacturing, political influence on the Fed, AI bubble burst, and rising debt issuance, amid ongoing economic uncertainty and shifting market dynamics.
-
San Francisco has filed a lawsuit against 11 major food companies, accusing them of marketing ultra-processed foods that contribute to health issues like obesity and diabetes. The city seeks penalties, consumer education, and restrictions on marketing, especially to children, citing scientific links to chronic illnesses.